Article Versions Notes

Paritala HR, Mier-y-Teran-Romero L, Natarajan R, Adams P, Spector C, Topf K, Kadambi A, Falvey JA, Lamias MJ, Durham DP, et al. Advancing Influenza Prevention: The Case for Pre-Exposure Prophylaxis (PrEP). Vaccines. 2026; 14(8):666. https://doi.org/10.3390/vaccines14080666

Paritala, Hanumantha Rao, Luis Mier-y-Teran-Romero, Ramya Natarajan, Peter Adams, Cassandra Spector, Katherine Topf, Ashwin Kadambi, Julia A. Falvey, Mark J. Lamias, David P. Durham, and et al. 2026. "Advancing Influenza Prevention: The Case for Pre-Exposure Prophylaxis (PrEP)" Vaccines 14, no. 8: 666. https://doi.org/10.3390/vaccines14080666

Paritala, H. R., Mier-y-Teran-Romero, L., Natarajan, R., Adams, P., Spector, C., Topf, K., Kadambi, A., Falvey, J. A., Lamias, M. J., Durham, D. P., & Armstrong, K. (2026). Advancing Influenza Prevention: The Case for Pre-Exposure Prophylaxis (PrEP). Vaccines, 14(8), 666. https://doi.org/10.3390/vaccines14080666